Unknown NA INTERVENTIONAL 1-arm NCT04629768

Purastat Prevention Delayed Bleeding Duodenum

A Study to Evaluate the Effectiveness of Purastat® in the Prevention of Delayed Bleeding After EMR of Non-ampullary Duodenal Lesions

Sponsor: 3-D Matrix Europe SAS

Conditions Lesion; Duodenum

Interventions PuraStat

Updated 6 times since 2020 Last updated: Nov 9, 2020 Started: Oct 2, 2020 Primary completion: Oct 31, 2022 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lesion; Duodenum and is currently ongoing. 3-D Matrix Europe SAS leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Oct 2022 — Oct 2023 [monthly]

Recruiting NA
Jan 2021 — Oct 2022 [monthly]

Recruiting NA

▶ Show 1 earlier version

Dec 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

3-D Matrix Europe SAS
Prof. Dr. Raf Bisschops

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium